Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYF2 pre-mRNA splicing factor pseudogene 1 (SYF2P1) is a human genomic processed pseudogene derived from the SYF2 gene, which encodes an RNA splicing factor involved in cell cycle regulation and DNA repair. As a pseudogene, SYF2P1 does not produce a functional protein and is generally not regarded as a drug target, enzyme, receptor, or transporter. Pseudogenes such as SYF2P1 can sometimes regulate the expression of their parent genes through transcriptional or post-transcriptional effects (e.g., formation of antisense RNA or competition for microRNA binding), but specific functional or disease-related roles for SYF2P1 have not been established in the literature. Its alias names reflect its origin from the SYF2 splicing factor and its related sequence homology, but references to it as a molecular target or active protein are incorrect. Key context: - SYF2, the parent gene, is functionally important in splicing, cell cycle regulation, and cancer biology, but SYF2P1 is a non-coding element and not a drug target or receptor. - Only the SYF2 gene/protein (not SYF2P1) has established biological functions, disease roles, and potential as a therapeutic target. - If requested information for the functional SYF2 protein or gene is needed, refer to “Pre-mRNA-splicing factor SYF2” (not its pseudogene derivative).
None. As a non-coding pseudogene, SYF2P1 has no mechanism of action for drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SYF2 pre-mRNA splicing factor pseudogene 1 (SYF2P1).